Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication

By Dr. Frederick D. Sancilio, MS, PHD | October 8, 2023

Published in Viuses 2022, 14(5), 912

Authors: Murray, Bergerson, Jones, Reener, Martin, Sancilio and Tripp

Summary: Dr. Ralph Tripp of the Department of Infectious Diseases, University of Georgia, Athens and his colleagues combined forces with Sancilio and their associates to form a new company called TrippBio, Inc. Utilizing the business expertise of a co-founder, Mr. Billy Meadow, the company began research relevant to the issue of the day: the global triple virus pandemic.

Ref: www.mdpi.com/1999-4915/14/5/912

Posted in Uncategorized